Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.
beta-Blockers prevent vascular events in patients after myocardial infarction and lower blood pressure, the main risk factor for stroke. Hence, we assessed the effects of atenolol on the occurrence of death from vascular causes, stroke, or myocardial infarction and on blood pressure in patients after a transient ischemic attack or nondisabling ischemic stroke. In a double-blind, placebo-controlled randomized clinical trial we studied the occurrence of the outcome event death from vascular causes, nonfatal stroke, or nonfatal myocardial infarction and the outcome event fatal or nonfatal stroke... Mehr ...
Dokumenttyp: | Artikel |
---|---|
Erscheinungsdatum: | 1993 |
Reihe/Periodikum: | Stroke ; volume 24, issue 4, page 543-548 ; ISSN 0039-2499 1524-4628 |
Verlag/Hrsg.: |
Ovid Technologies (Wolters Kluwer Health)
|
Schlagwörter: | Advanced and Specialized Nursing / Cardiology and Cardiovascular Medicine / Neurology (clinical) |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26657469 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1161/01.str.24.4.543 |